The complex role of HBeAg and its precursors in the pathway to hepatocellular carcinoma
K Padarath, A Deroubaix, A Kramvis - Viruses, 2023 - mdpi.com
Hepatitis B virus (HBV) is one of the seven known human oncogenic viruses and has
adapted to coexist with a single host for prolonged periods, requiring continuous …
adapted to coexist with a single host for prolonged periods, requiring continuous …
Regulation of pattern-recognition receptor signaling by HBX during hepatitis B virus infection
H You, S Qin, F Zhang, W Hu, X Li, D Liu… - Frontiers in …, 2022 - frontiersin.org
As a small DNA virus, hepatitis B virus (HBV) plays a pivotal role in the development of
various liver diseases, including hepatitis, cirrhosis, and liver cancer. Among the molecules …
various liver diseases, including hepatitis, cirrhosis, and liver cancer. Among the molecules …
MicroRNA-196a/-196b regulate the progression of hepatocellular carcinoma through modulating the JAK/STAT pathway via targeting SOCS2
W Ren, S Wu, Y Wu, T Liu, X Zhao, Y Li - Cell death & disease, 2019 - nature.com
Abstract microRNAs (miRNAs) play essential roles in progression of hepatocellular
carcinoma (HCC). However, the roles of miR-196a and miR-196b as well as mechanism in …
carcinoma (HCC). However, the roles of miR-196a and miR-196b as well as mechanism in …
Hepatitis B virus–induced imbalance of inflammatory and antiviral signaling by differential phosphorylation of STAT1 in human monocytes
H Song, G Tan, Y Yang, A Cui, H Li, T Li… - The Journal of …, 2019 - journals.aai.org
It is not clear how hepatitis B virus (HBV) modulates host immunity during chronic infection.
In addition to the key mediators of inflammatory response in viral infection, monocytes also …
In addition to the key mediators of inflammatory response in viral infection, monocytes also …
Differential activation of NLRP3, AIM2, and IFI16 inflammasomes in humans with acute and chronic hepatitis B
H Chen, G He, Y Chen, X Zhang, S Wu - Viral immunology, 2018 - liebertpub.com
Nod-like receptor protein 3 (NLRP3), absent in melanoma 2 (AIM2), and interferon gamma
inducible protein 16 (IFI16) are innate immune sensors for intracellular microbes, which can …
inducible protein 16 (IFI16) are innate immune sensors for intracellular microbes, which can …
[HTML][HTML] Higher TP53BP2 expression is associated with HBsAg loss in peginterferon-α-treated patients with chronic hepatitis B
G Guan, T Zhang, J Ning, C Tao, N Gao, Z Zeng… - Journal of …, 2024 - Elsevier
Background & Aims HBsAg loss is only observed in a small proportion of patients with
chronic hepatitis B (CHB) who undergo interferon treatment. Investigating the host factors …
chronic hepatitis B (CHB) who undergo interferon treatment. Investigating the host factors …
IFIT3 Is Increased in Serum from Patients with Chronic Hepatitis B Virus (HBV) Infection and Promotes the Anti-HBV Effect of Interferon Alpha via JAK-STAT2 In Vitro
S Xu, J Huang, Z Xun, S Li, Y Fu, N Lin… - Microbiology …, 2022 - Am Soc Microbiol
Increasing evidence indicates that interferon alpha (IFN-α) therapy is an effective treatment
option for a subgroup of patients with chronic hepatitis B virus (HBV) infection. It has been …
option for a subgroup of patients with chronic hepatitis B virus (HBV) infection. It has been …
Hepatitis B virus e antigen and viral persistence
Highlights•Maternal HBeAg impacts Kupffer cells of the offspring to promote HBV
persistence.•HBeAg interacts with regulatory T cells to suppress natural killer cell …
persistence.•HBeAg interacts with regulatory T cells to suppress natural killer cell …
Treatment of Liver Fibrosis after Hepatitis B with TCM Combined with NAs Evaluated by Noninvasive Diagnostic Methods: A Retrospective Study
L Ying, Z Pan, Z Lin-Yi, H Wan-Er… - Evidence‐Based …, 2023 - Wiley Online Library
Objective. Chronic hepatitis B liver fibrosis is an important intermediate link in the
development of liver cirrhosis. A retrospective cohort study was conducted in Longhua …
development of liver cirrhosis. A retrospective cohort study was conducted in Longhua …
Specific determination of hepatitis B e antigen by antibodies targeting precore unique epitope facilitates clinical diagnosis and drug evaluation against hepatitis B virus …
SJ Wang, ZM Chen, M Wei, JQ Liu, ZL Li… - Emerging microbes & …, 2021 - Taylor & Francis
Hepatitis B e antigen (HBeAg) is a widely used marker both for chronic hepatitis B (CHB)
clinical management and HBV-related basic research. However, due to its high amino acid …
clinical management and HBV-related basic research. However, due to its high amino acid …